MedPage Today

MedPage Today
Share

MedPage Today

 •  January 22

New blood vessels that grow in response to cardiac ischemia appeared in a mouse model to be partly from clonal expansion of endothelial cells -- a discovery that might open up new treatment pathways, researchers wrote in Circulation Research. "Hot yoga" isn't better for the heart than yoga done at regular room temperature, researchers found....

MedPage Today

 •  January 16

The FDA cleared the Riptide Aspiration System for the endovascular revascularization of acute ischemic stroke secondary to intracranial large vessel occlusions, manufacturer Medtronic announced. Riptide is indicated for patients who present within 8 hours of symptom onset and who are ineligible for IV tPA therapy. Aspiration thrombectomy does not...

MedPage Today

 •  December 8, 2017

Thrombolytics delivered to acute proximal deep-vein thrombus (DVT) with clot removal did not reduce the risk of post-thrombotic syndrome but did raise major bleeding risk over anticoagulant treatment alone in the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) clinical trial. The proportion of...

MedPage Today

 •  November 8, 2017

NEW ORLEANS -- Patients with failing kidneys may soon be able to get an arteriovenous fistula for hemodialysis without surgery, a researcher reported here. The Ellipsys Vascular Access System -- a single-catheter, image-guided vascular access system for hemodialysis -- met its primary efficacy endpoint of brachial artery flow volume ≥500 ml/min and...

MedPage Today

 •  October 19, 2017

Giving IV fentanyl (Sublimaze) for pain control during coronary angiography may hamper the antiplatelet effect of ticagrelor (Brilinta) during percutaneous coronary intervention (PCI), a trial showed. Of 212 adults randomized to elective coronary angiography with or without IV fentanyl, 70 required PCI and were loaded with 180-mg ticagrelor after...

MedPage Today

 •  June 23, 2017

Inpatient medicine is one of the most challenging aspects of full-scope family medicine. The pace is fast, the patients are truly sick, and the rapid patient turnover can make your head spin. With an emphasis on patient disposition and the increasing use of skilled nursing facilities to bridge the gap between hospital and home, patients frequently...

MedPage Today

 •  May 30, 2017

SAN DIEGO -- The central question when starting treatment for a newly diagnosed relapsing remitting multiple sclerosis (RRMS) patient is essentially this: do you come out swinging, or do you take a more step-wise approach? With 15 disease-modifying therapies available -- ranging in impact from the old staple of interferon injections to more potent...

MedPage Today

 •  May 28, 2017

NEW ORLEANS -- Treatment with ublituximab, an investigational glycoengineered anti-CD20 antibody, was well tolerated and demonstrated rapid and robust B-cell depletion in patients with relapsing or primary progressive multiple sclerosis (MS), researchers reported here. "Ublituximab efficiently depletes 99% of B cells, meeting the endpoint of the...

MedPage Today

 •  March 7, 2017

WASHINGTON -- Anticoagulants alone remained the best course of therapy for deep vein thrombosis (DVT) -- though patients with iliofemoral disease showed a signal of benefit from pharmacomechanical catheter-directed thrombolysis (PCDT), according to the ATTRACT randomized trial. By the Villalta Scale there was no difference in rates of...

MedPage Today

 •  February 2, 2017

WASHINGTON -- Antiseptic solutions, washes, sponges, and other products containing chlorhexidine gluconate may carry a slight risk of causing severe allergic reactions including anaphylaxis, the FDA said Thursday. The agency said it had identified 52 cases of anaphylaxis in individuals worldwide in the past 70 years who had used chlorhexidine...